Gene | Associated with MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME in | Link to HGNC | Cytogenetic band | Number of associated diseases | Associated diseases |
---|---|---|---|---|---|
AKT3 | ClinVar, OMIM, HUMSAVAR | HGNC link | 1q44 | 1 | PS603387 |
PIK3R2 | ClinVar, OMIM, HUMSAVAR | HGNC link | 19p13.11 | 1 | PS603387 |
CCND2 | ClinVar, OMIM, HUMSAVAR | HGNC link | 12p13.32 | 1 | PS603387 |
Download the disease annotation in CSV format
regulated gene | associated to this disease | # TFs | TFs | # TFs associated with this disease | TFs associated with this disease |
---|---|---|---|---|---|
CCND2 | YES | 24 | NFYA, ABL1, GATA4, FOXL2, TRRAP, RUNX1, NFKB2, SP1, ETV4, BCL6, EGR1, STAT5A, FOXO3, HDAC1, NFYB, NFYC, JUN, RELA, NFKB1, STAT3, MAFB, MYC, MAF, IRF9 | 0 |
Gene1 | Gene2 | Direct Interaction | Number of shared interactors | Shared genes in interaction |
---|---|---|---|---|
PIK3R2 | CCND2 | No | 2 | FBXL2, ABL1 |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
Gene1 | Gene2 | Direct Interaction | Interaction mode | Number of shared interactors | Shared genes in interaction |
---|---|---|---|---|---|
AKT3 | PIK3R2 | No | - | 4 | PIK3CB, PIK3CD, PIK3CA, PIK3CG |
AKT3 | CCND2 | No | - | 7 | CDKN1A, IGF1, TSC2, FOXO1, FOXO3, GSK3B, CDKN1B |
Direct interactions graph
Interactions graph (direct and indirect interactions, when direct are not available)
KEGG term | KEGG term ID | IC | Number of genes with the same term | Genes |
---|---|---|---|---|
FoxO signaling pathway | hsa04068 | 5.63 | 3 | AKT3, CCND2, PIK3R2 |
Jak-STAT signaling pathway | hsa04630 | 5.44 | 3 | AKT3, CCND2, PIK3R2 |
Prolactin signaling pathway | hsa04917 | 6.6 | 3 | AKT3, CCND2, PIK3R2 |
Focal adhesion | hsa04510 | 4.92 | 3 | AKT3, CCND2, PIK3R2 |
HTLV-I infection | hsa05166 | 4.59 | 3 | AKT3, CCND2, PIK3R2 |
Measles | hsa05162 | 5.6 | 3 | AKT3, CCND2, PIK3R2 |
PI3K-Akt signaling pathway | hsa04151 | 4.21 | 3 | AKT3, CCND2, PIK3R2 |
Melanoma | hsa05218 | 6.56 | 2 | AKT3, PIK3R2 |
Platelet activation | hsa04611 | 5.66 | 2 | AKT3, PIK3R2 |
Acute myeloid leukemia | hsa05221 | 6.74 | 2 | AKT3, PIK3R2 |
cGMP-PKG signaling pathway | hsa04022 | 5.32 | 2 | AKT3, PIK3R2 |
Endometrial cancer | hsa05213 | 6.81 | 2 | AKT3, PIK3R2 |
Colorectal cancer | hsa05210 | 6.52 | 2 | AKT3, PIK3R2 |
Renal cell carcinoma | hsa05211 | 6.6 | 2 | AKT3, PIK3R2 |
Signaling pathways regulating pluripotency of stem cells | hsa04550 | 5.6 | 2 | AKT3, PIK3R2 |
Glioma | hsa05214 | 6.66 | 2 | AKT3, PIK3R2 |
Prostate cancer | hsa05215 | 6.11 | 2 | AKT3, PIK3R2 |
Neurotrophin signaling pathway | hsa04722 | 5.78 | 2 | AKT3, PIK3R2 |
Central carbon metabolism in cancer | hsa05230 | 6.7 | 2 | AKT3, PIK3R2 |
Choline metabolism in cancer | hsa05231 | 6.09 | 2 | AKT3, PIK3R2 |
Osteoclast differentiation | hsa04380 | 5.64 | 2 | AKT3, PIK3R2 |
HIF-1 signaling pathway | hsa04066 | 5.9 | 2 | AKT3, PIK3R2 |
Chemokine signaling pathway | hsa04062 | 5.19 | 2 | AKT3, PIK3R2 |
Rap1 signaling pathway | hsa04015 | 4.97 | 2 | AKT3, PIK3R2 |
Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 | 2 | AKT3, PIK3R2 |
Pancreatic cancer | hsa05212 | 6.56 | 2 | AKT3, PIK3R2 |
Epstein-Barr virus infection | hsa05169 | 4.97 | 2 | AKT3, PIK3R2 |
Toxoplasmosis | hsa05145 | 5.71 | 2 | AKT3, PIK3R2 |
Influenza A | hsa05164 | 5.21 | 2 | AKT3, PIK3R2 |
Apoptosis | hsa04210 | 6.23 | 2 | AKT3, PIK3R2 |
Hepatitis C | hsa05160 | 5.68 | 2 | AKT3, PIK3R2 |
Hepatitis B | hsa05161 | 5.52 | 2 | AKT3, PIK3R2 |
Chronic myeloid leukemia | hsa05220 | 6.48 | 2 | AKT3, PIK3R2 |
VEGF signaling pathway | hsa04370 | 6.77 | 2 | AKT3, PIK3R2 |
Proteoglycans in cancer | hsa05205 | 5.02 | 2 | AKT3, PIK3R2 |
MicroRNAs in cancer | hsa05206 | 5.38 | 2 | CCND2, PIK3R2 |
Toll-like receptor signaling pathway | hsa04620 | 6.0 | 2 | AKT3, PIK3R2 |
Pathways in cancer | hsa05200 | 3.98 | 2 | AKT3, PIK3R2 |
Viral carcinogenesis | hsa05203 | 5.08 | 2 | CCND2, PIK3R2 |
T cell receptor signaling pathway | hsa04660 | 6.01 | 2 | AKT3, PIK3R2 |
Fc gamma R-mediated phagocytosis | hsa04666 | 6.21 | 2 | AKT3, PIK3R2 |
B cell receptor signaling pathway | hsa04662 | 6.52 | 2 | AKT3, PIK3R2 |
Ras signaling pathway | hsa04014 | 4.9 | 2 | AKT3, PIK3R2 |
Non-small cell lung cancer | hsa05223 | 6.88 | 2 | AKT3, PIK3R2 |
Small cell lung cancer | hsa05222 | 6.17 | 2 | AKT3, PIK3R2 |
Progesterone-mediated oocyte maturation | hsa04914 | 6.18 | 2 | AKT3, PIK3R2 |
Estrogen signaling pathway | hsa04915 | 6.11 | 2 | AKT3, PIK3R2 |
TNF signaling pathway | hsa04668 | 5.96 | 2 | AKT3, PIK3R2 |
Thyroid hormone signaling pathway | hsa04919 | 5.82 | 2 | AKT3, PIK3R2 |
AMPK signaling pathway | hsa04152 | 5.8 | 2 | AKT3, PIK3R2 |
mTOR signaling pathway | hsa04150 | 6.72 | 2 | AKT3, PIK3R2 |
Carbohydrate digestion and absorption | hsa04973 | 7.28 | 2 | AKT3, PIK3R2 |
Insulin signaling pathway | hsa04910 | 5.55 | 2 | AKT3, PIK3R2 |
cAMP signaling pathway | hsa04024 | 5.05 | 2 | AKT3, PIK3R2 |
Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 | 2 | AKT3, PIK3R2 |
Cholinergic synapse | hsa04725 | 5.88 | 2 | AKT3, PIK3R2 |
Fc epsilon RI signaling pathway | hsa04664 | 6.6 | 2 | AKT3, PIK3R2 |
Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 | 2 | AKT3, PIK3R2 |
ErbB signaling pathway | hsa04012 | 6.15 | 2 | AKT3, PIK3R2 |
REACTOME term | REACTOME term ID | IC | Number of genes with the same term | Genes |
---|---|---|---|---|
PI3K/AKT activation | R-HSA-198203 | 6.32 | 2 | AKT3, PIK3R2 |
GPVI-mediated activation cascade | R-HSA-114604 | 7.18 | 2 | AKT3, PIK3R2 |
Immune System | R-HSA-168256 | 2.37 | 2 | AKT3, PIK3R2 |
Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 | 2 | AKT3, PIK3R2 |
Downstream signal transduction | R-HSA-186763 | 4.65 | 2 | AKT3, PIK3R2 |
GAB1 signalosome | R-HSA-180292 | 6.31 | 2 | AKT3, PIK3R2 |
Signaling by ERBB4 | R-HSA-1236394 | 4.7 | 2 | AKT3, PIK3R2 |
Adaptive Immune System | R-HSA-1280218 | 3.19 | 2 | AKT3, PIK3R2 |
Disease | R-HSA-1643685 | 3.33 | 2 | AKT3, PIK3R2 |
Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 | 2 | AKT3, PIK3R2 |
Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 | 2 | AKT3, PIK3R2 |
Signalling by NGF | R-HSA-166520 | 4.23 | 2 | AKT3, PIK3R2 |
Signaling by VEGF | R-HSA-194138 | 4.66 | 2 | AKT3, PIK3R2 |
PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 | 2 | AKT3, PIK3R2 |
CD28 co-stimulation | R-HSA-389356 | 7.98 | 2 | AKT3, PIK3R2 |
CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.59 | 2 | AKT3, PIK3R2 |
Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 | 2 | AKT3, PIK3R2 |
DAP12 signaling | R-HSA-2424491 | 4.64 | 2 | AKT3, PIK3R2 |
Signaling by FGFR4 | R-HSA-5654743 | 4.69 | 2 | AKT3, PIK3R2 |
Signaling by FGFR3 | R-HSA-5654741 | 4.69 | 2 | AKT3, PIK3R2 |
VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.7 | 2 | AKT3, PIK3R2 |
Signaling by FGFR | R-HSA-190236 | 4.67 | 2 | AKT3, PIK3R2 |
PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 | 2 | AKT3, PIK3R2 |
Diseases of signal transduction | R-HSA-5663202 | 4.89 | 2 | AKT3, PIK3R2 |
Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 | 2 | AKT3, PIK3R2 |
GPCR downstream signaling | R-HSA-388396 | 3.07 | 2 | AKT3, PIK3R2 |
Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 | 2 | AKT3, PIK3R2 |
Innate Immune System | R-HSA-168249 | 3.17 | 2 | AKT3, PIK3R2 |
Signaling by SCF-KIT | R-HSA-1433557 | 4.73 | 2 | AKT3, PIK3R2 |
PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 | 2 | AKT3, PIK3R2 |
Signaling by PDGF | R-HSA-186797 | 4.53 | 2 | AKT3, PIK3R2 |
G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.4 | 2 | AKT3, PIK3R2 |
PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 | 2 | AKT3, PIK3R2 |
PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 | 2 | AKT3, PIK3R2 |
Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 | 2 | AKT3, PIK3R2 |
Signaling by EGFR | R-HSA-177929 | 4.59 | 2 | AKT3, PIK3R2 |
NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 | 2 | AKT3, PIK3R2 |
PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 | 2 | AKT3, PIK3R2 |
Signaling by GPCR | R-HSA-372790 | 2.68 | 2 | AKT3, PIK3R2 |
Signaling by FGFR2 | R-HSA-5654738 | 4.68 | 2 | AKT3, PIK3R2 |
Signaling by FGFR1 | R-HSA-5654736 | 4.69 | 2 | AKT3, PIK3R2 |
PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 | 2 | AKT3, PIK3R2 |
G-protein beta:gamma signalling | R-HSA-397795 | 7.31 | 2 | AKT3, PIK3R2 |
Hemostasis | R-HSA-109582 | 3.98 | 2 | AKT3, PIK3R2 |
PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 | 2 | AKT3, PIK3R2 |
DAP12 interactions | R-HSA-2172127 | 4.56 | 2 | AKT3, PIK3R2 |
Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 | 2 | AKT3, PIK3R2 |
Signaling by ERBB2 | R-HSA-1227986 | 4.66 | 2 | AKT3, PIK3R2 |
Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 | 2 | AKT3, PIK3R2 |
Signal Transduction | R-HSA-162582 | 1.78 | 2 | AKT3, PIK3R2 |
Costimulation by the CD28 family | R-HSA-388841 | 6.56 | 2 | AKT3, PIK3R2 |
GO | IC | Number of genes with the same GO | Genes |
---|---|---|---|
binding (GO:0005488) | 0.18 | 3 | AKT3, CCND2, PIK3R2 |
protein binding (GO:0005515) | 0.46 | 3 | AKT3, CCND2, PIK3R2 |
catalytic activity (GO:0003824) | 1.05 | 2 | AKT3, PIK3R2 |
phosphotransferase activity, alcohol group as acceptor (GO:0016773) | 3.08 | 2 | AKT3, PIK3R2 |
transferase activity, transferring phosphorus-containing groups (GO:0016772) | 2.77 | 2 | AKT3, PIK3R2 |
kinase activity (GO:0016301) | 2.93 | 2 | AKT3, PIK3R2 |
enzyme binding (GO:0019899) | 2.27 | 2 | CCND2, PIK3R2 |
protein kinase binding (GO:0019901) | 3.44 | 2 | CCND2, PIK3R2 |
kinase binding (GO:0019900) | 3.32 | 2 | CCND2, PIK3R2 |
transferase activity (GO:0016740) | 1.95 | 2 | AKT3, PIK3R2 |
Term | New enriched term | IC | P value | Genes |
---|---|---|---|---|
regulation of small GTPase mediated signal transduction (GO:0051056) | NEW | 4.08 | 0.028 | AKT3, CCND2, PIK3R2 |